Clive has over 20 years' experience in the pharmaceutical and biotechnology industries. He was CEO and co-founder of PowderMed Limited, which was sold to Pfizer Inc. in 2006. Following post-doctoral roles and a period at Ciba-Geigy AG (now Novartis AG), Clive joined GlaxoWellcome plc where he became UK Research Director.
Other previous roles include: Senior Vice President of research and development at PowderJect Pharmaceuticals plc, Chairman of the UK BioIndustry Association and Chairman of Auralis Limited (acquired by ViroPharma Inc).
Clive is currently CEO of Convergence Pharmaceuticals Limited and Chairman of Crescendo Biologicals Limited and Touchlight Genetics Limited.